Back to Browse Journals » ClinicoEconomics and Outcomes Research » Volume 1

Management strategies and cost effectiveness in the prevention of cervical cancer

Authors Smita R Prasad

Published 5 June 2009 Volume 2009:1 Pages 17—23


Review by Single-blind

Peer reviewer comments 3

Smita R Prasad

University of Kentucky, College of Public Health, Lexington, KY, USA

Abstract: This paper introduces the burden of cervical cancer and the primary and secondary preventative interventions currently available, and provides an overview of the bivalent and quadrivalent human papillomavirus (HPV) vaccines. A brief account of the virology and the clinical efficacy of both is given. Examinations of the two main types of cost analyses, cost-effective and cost-benefit, as well as examples, are presented in addition to the possible impact these analyses and further economic models will have on budget and policy making decisions. In general, most cost analyses provide support for the implementation of primary prevention strategies, HPV immunization, in conjunction with cervical cancer screening programs. Vaccination against HPV, therefore, is a cost-effective cervical cancer prevention mechanism.

Keywords: cervical cancer, human papillomavirus, HPV

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Shared decision-making in the People’s Republic of China: current status and future directions

Huang RC, Gionfriddo MR, Zhang LZ, Leppin AL, Ting HH, Montori VM

Patient Preference and Adherence 2015, 9:1129-1141

Published Date: 6 August 2015

Impact of noncommunicable diseases in the State of Qatar

Al-Kaabi SK, Atherton A

ClinicoEconomics and Outcomes Research 2015, 7:377-385

Published Date: 2 July 2015

Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid

Nanda SS, An SS, Yi DK

International Journal of Nanomedicine 2015, 10:549-556

Published Date: 12 January 2015

Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia

Shafie AA, Lim YW, Chua GN, Hassali MA

ClinicoEconomics and Outcomes Research 2014, 6:473-481

Published Date: 23 October 2014

Duloxetine treatment adherence across mental health and chronic pain conditions

Able SL, Cui Z, Shen W

ClinicoEconomics and Outcomes Research 2014, 6:75-81

Published Date: 11 February 2014

Family medicine’s rapid establishment and early leadership role in Qatar’s health care system

Verjee MA, Abdulmalik MA, Fetters MD

Journal of Healthcare Leadership 2013, 5:47-52

Published Date: 12 August 2013

Critical appraisal of ranibizumab in the treatment of diabetic macular edema

Stewart MW

Clinical Ophthalmology 2013, 7:1257-1267

Published Date: 24 June 2013

Topical azithromycin or ofloxacin for endophthalmitis

Stewart MW, Stewart ML

Clinical Ophthalmology 2013, 7:35-38

Published Date: 31 December 2012

Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes

Barnett AH

Core Evidence 2011, 6:67-79

Published Date: 8 September 2011